Upcoming Medical Conferences in Puerto Vallarta

Cardiology Update at Puerto Vallarta: A Focus on Prevention is organized by Mayo Clinic and will be held from Jan 07 - 11, 2019 at Marriott Puerto Vallarta Resort & Spa, Puerto Vallarta, Jalisco, Mexico. The target audience for this medical event is healthcare professionals in practice or in training who are interested in preventive cardiology. This may include physicians, nurse practitioners, physician assistants, nurses, exercise specialists, dieticians, health coaches, and others. This CME Conference has been approved for a maximum of 20.5 AMA PRA Category 1 Credits Course Description : The purpose of the meeting is to present state-of-the-art knowledge in cardiology with a clinically-based approach. The scope of the program is broad and will cover a wide spectrum of cardiovascular diseases but generally focused on prevention of coronary disease, stroke and sudden death. Expert faculty will present practical clinical approaches to diagnostics and latest management strategies of challenging and controversial topics in cardiology. Course Objectives are: Upon conclusion of this program, participants should be able to: • Identify basic and advanced screening strategies to identify CVD risk in clinical practice • Select evidence-based lifestyle and medication management strategies to manage CVD risk factors • Recognize indications for and impact of medication and surgical management of obesity • Cite the critical steps in management of patients with known CVD, including CAD, heart failure, atrial fibrillation, stroke, valvular heart disease, thromboembolic events • Recognize effective methods to identify and manage CVD risk in younger and older athletes • Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course. Time:7:00 am to 12:00 pm  

22nd Annual Anesthesia meeting in Puerto Vallarta is organized by University of Michigan Medical School and will be held from Feb 03 - 08, 2019 at The Westin Resort & Spa, Puerto Vallarta, Puerto Vallarta, Jalisco, Mexico. This CME Conference has been approved for a maximum of 25 AMA PRA Category 1 Credits. Conference Description: This course is designed to provide the anesthesia provider with a review of the most recent information on many of the components that go into making a successful practice of anesthesiology. This meeting will focus on practical updates in the clinical subspecialty areas in our field. The conference will include topics in the areas of acute postsurgical care prescribing of opioids and the role in the opioid epidemic, as well as the impact of the opioid crisis on pediatric surgical populations. Additional pediatric topics will include anesthetic management concerns associated with Trisomy 21, 18, and 13, and the role of perioperative glucose management in the neonatal population. Topics in Neuroanesthesiology include updates in the management of acute stroke patients, traumatic brain injury, and recent guidelines in the management of extraventricular drains. Cardiac Anesthesia topics will include management unique to the cardiac catheterization laboratory and an update in atrial fibrillation. Additional adult content will include ambulatory anesthesia, advances in peripheral regional anesthesia, renal failure, and its associated fluid management, and the role of newer anti-coagulants in patient care. Airway management topics will include those related to the trauma patient, laryngotracheal complications following intubation, and perioperative management of tracheostomies and other airway devices. Systems based topics will include: Anesthesiologist as the second victim in crisis management, evolving health economic policy and implications for Anesthesiologists, the epidemiology and consequences of perioperative medication errors, and how Anesthesiologists are optimally positioned as leaders in perioperative care. And as usual, we will end each day’s session with a case presentation and clinical discussion.

Metabolism in Health and Disease Conference 2019 is organized by Fusion Conferences Ltd and will be held from May 24 - 27, 2019 at Fiesta Americana, Puerto Vallarta, Jalisco, Mexico. The target audience for this medical event is researchers interested in connecting metabolism to cancer, inflammatory diseases, stem cells and aging in both academia and the biotech/pharma industries. Interested researchers need to be on top of these interconnected fields and will want to participate in an international meeting serving as platform for presentation and discussion of the most up-to-date preclinical and clinical work emerging from them. Conference Description: The new millennium has seen a resurgence in our appreciation of metabolism as a central discipline in our understanding of human health and disease. Although the pathways necessary for ATP production and synthesis of macromolecules (nucleic acids, lipids, and amino acids) were elucidated decades ago, their role in determining cell fate or function has been uncovered only recently. The discovery that oncogenes and tumour suppressors reprogram nutrient uptake and metabolism in malignant cells has re-energized the field of cancer metabolism and more broadly stimulated a second “golden age” of disease-oriented research in biochemistry. Recent work has also shown that metabolites themselves influence signal transduction and gene expression, indicating a surprising degree of crosstalk between metabolism and other regulatory networks in cells and tissues. Metabolites are also important in communication between cells both within a tissue and systemically throughout the body. At this conference we will discuss the role of metabolism in controlling cell fate and function in multiple contexts including cancer, tissue regeneration, immune responses and aging. Speakers:Janelle Ayres (Salk Insitute), Kivanc Birsoy (Rockefeller University), Edward Chouchani (Dana-Farber Cancer Institute), Heather Christofk (University of California, Los Angeles), Maralice Conacci-Sorrell (UT Southwestern Medical Center), Andy Dillin (UC Berkeley), Gerard Evan (University of Cambridge), Mark Febbraio (Garvan Institute), Douglas Green (St. Jude Children's Research Hospital), Marcia Haigis (Harvard Medical School), Russell Jones (McGill University), Brendan Manning (Harvard T.H. Chan), Christian Metallo (UC San Diego), Thales Papagiannakopoulos (NYU School of Medicine), Erika Pearce (Max Planck Institute), Jared Rutter (University of Utah), David Sabatini (Whitehead Institute for Biomedical Research), Gerald Shadel (Salk Insititute), Celeste Simon (University of Pennsylvania), Poul Sorensen (The University of British Colombia), Matthew Vander Heiden (Massachusetts Institute of Technology). Additional details will be posted as soon as they are available.

3rd Personalized Medicine Conference is organized by Fusion Conferences Ltd and will be held from May 30 - Jun 02, 2019 at American Fiesta, Puerto Vallarta, Jalisco, Mexico. The target audience for this medical event is broad spectrum of researchers working on Personalized Medicine and will include Pathologists, Geneticists, Genetic Counsellors, Clinical Pharmacists, Pharmacologists, Data Scientists and Bioinformaticians. Course Description: New diagnostic technologies and therapeutic approaches are being developed and implemented which will transform patient management in the near future. As with the previous two meetings, this conference will include academic scientists and industry leaders. In addition to topics discussed at the previous personalized medicine conferences, for 2019 we plan to add speakers in particularly timely topics such as pharmacogenomics, machine learning, and high throughput drug screening, all of which have the potential to truly transform the practice of medicine. Attendees at the previous Personalized Medicine Conferences found the mix of topics stimulating and informative. Course Key Sessions: • Overviews of Personalized Medicine/Precision Medicine. • Precision Diagnostics. • Cancer Genomics. • Biomarkers. • Computational Imaging. • Bioinformatics. • Machine Learning/Artificial Intelligence. • Big Data/ Data Science. • Pharmacogenomics. • Wearable technology. • Ethics panel. • High throughput drug screening of patient tumor cells to personalize cancer care. Additional details will be posted as soon as they are available.